May 27, 2021
Axxam is proud to announce the entire acquisition of the share capital of Hit Discovery Constance GmbH (“HDC”). As a consequence, HDC founded in 2014 as a joint venture between Axxam, Centre for Drug Design and Discovery of KU Leuven and Lead Discovery Center GmbH, is now a subsidiary of Axxam. HDC is a company located in Constance, which is an attractive environment for life science-based companies with access to a great talent pool. Now fully belonging to the Axxam Group, HDC adds to Axxam’s portfolio by expanding our complementary technological platforms and scientific expertise, including high-throughput screening, high-content and radiometric screening, as well as compound storage and management services. Particularly noteworthy is the capability for acoustic dispensing which allows for HTS in 1536 well format.